Literature DB >> 355574

The immunologic response to infection with respiratory syncytial virus in infants.

K McIntosh, H B Masters, I Orr, R K Chao, R M Barkin.   

Abstract

Fifty infants younger than six months, hospitalized for infection with respiratory syncytial virus (RSV), were studied by examination of serial samples of nasal secretion. Secretory neutralizing activity was measured by plaque reduction and secretory antibody by indirect fluorescence using conjugated antiserum to human IgA, IgG, or IgM. Secretory neutralizing activity during infection rose or fell fourfold with approximately equal frequency (20% and 26%, respectively). In contrast, levels of IgA antibody to RSV in secretions rose fourfold in 56%--65% of the infants and fell in none. The frequency of such rises in titer of antibody was directly related to age. In individual secretions the correlation between neutralizing activity and IgA antibody to RSV was poor: neutralizing activity was often found in the absence of detectable antibody, and IgA antibody to RSV was often nonneutralizing. Nevertheless, the development of IgA antibody to RSV correlated in time with the disappearance of virus from the respiratory tract. The timing of this secretory response is consistent with the hypothesis that antibody contributes significantly to cure of infection.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 355574     DOI: 10.1093/infdis/138.1.24

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  53 in total

Review 1.  Development of local immunity: role in mechanisms of protection against or pathogenesis of respiratory syncytial viral infections.

Authors:  D Nadal; P L Ogra
Journal:  Lung       Date:  1990       Impact factor: 2.584

2.  Antibody response to respiratory syncytial virus infection in children <18 months old.

Authors:  Susanna Esposito; Elisa Scarselli; Mara Lelii; Alessia Scala; Alessandra Vitelli; Stefania Capone; Marco Fornili; Elia Biganzoli; Annalisa Orenti; Alfredo Nicosia; Riccardo Cortese; Nicola Principi
Journal:  Hum Vaccin Immunother       Date:  2016-02-22       Impact factor: 3.452

Review 3.  Immunity to human and bovine respiratory syncytial virus.

Authors:  T G Kimman; F Westenbrink
Journal:  Arch Virol       Date:  1990       Impact factor: 2.574

4.  Coproantibody response to rotavirus in an outbreak in a day-care nursery.

Authors:  T Shinozaki; K Araki; H Ushijima; B Kim; T Tajima; R Fujii; M Minamitani
Journal:  Eur J Pediatr       Date:  1986-02       Impact factor: 3.183

Review 5.  Vaccine Design Informed by Virus-Induced Immunity.

Authors:  Rhiannon R Penkert; Jane S Hankins; Neal S Young; Julia L Hurwitz
Journal:  Viral Immunol       Date:  2020-05-05       Impact factor: 2.257

6.  Respiratory virus infection in hospitalized children in Austria 1979-1982. Diagnosis by immunofluorescence.

Authors:  T Popow-Kraupp; C Kunz; E Huber
Journal:  Infection       Date:  1984 May-Jun       Impact factor: 3.553

7.  Intranasal administration of retinyl palmitate with a respiratory virus vaccine corrects impaired mucosal IgA response in the vitamin A-deficient host.

Authors:  Sherri L Surman; Bart G Jones; Rajeev Rudraraju; Robert E Sealy; Julia L Hurwitz
Journal:  Clin Vaccine Immunol       Date:  2014-02-19

Review 8.  The immune response to respiratory syncytial virus infection: friend or foe?

Authors:  Robert C Welliver
Journal:  Clin Rev Allergy Immunol       Date:  2008-04       Impact factor: 8.667

Review 9.  Hyperimmune globulins in prevention and treatment of respiratory syncytial virus infections.

Authors:  V G Hemming; G A Prince; J R Groothuis; G R Siber
Journal:  Clin Microbiol Rev       Date:  1995-01       Impact factor: 26.132

10.  Secretory immunological response in infants and children to parainfluenza virus types 1 and 2.

Authors:  R Yanagihara; K McIntosh
Journal:  Infect Immun       Date:  1980-10       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.